Article Text

PDF
What is the role of ethics committees after Regulation (EU) 536/2014?
  1. Carlo Petrini
  1. Correspondence to Dr Carlo Petrini, Bioethics Unit, Office of the President, Italian National Institute of Health (Istituto Superiore di Sanità), Via Giano della Bella 34, Rome I-00162, Italy; carlo.petrini{at}iss.it

Abstract

EU Regulation 536/2014 stipulates that when assessing applications for authorisation to conduct clinical trials, Member States should formulate a ‘single decision’. This raises the problem of identifying: (1) the facility designated to express this ‘single decision’ and (2) the role of ethics committees in the decision-making process. The article addresses the consequences of the requirement that for each Member State the assessment of an application for approval to conduct a trial must take the form of a ‘single decision’ by the Member State concerned. Three possible approaches to the procedures for expressing that ‘single decision’ and to the role of ethics committees in the decision-making process are described, one of which is indicated as the preferred option.

  • Clinical trials
  • Ethics Committees/Consultation
  • Law
  • Regulation

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles